Search for Clinical Trial Results
Rhabdoid Tumor - 13 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma Condition: Malignant Rhabdoid Tumors (MRT), Neuroblastoma Date: 2012-12-06 Interventions: Drug: LEE011 LEE011 is a small molecule inhibitor of CDK4/6. |
Active, not recruiting |
Study Name: Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Date: 2008-04-03 Interventions:
|
Recruiting |
Study Name: Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors Condition:
|
Terminated |
Study Name: Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System Condition: Rhabdoid Neoplasm of CNS Date: 1999-11-01 Interventions: Drug: Antineoplaston therapy (Atengenal + Astugenal) Children with a Rhabdoid tumor will receive Antineo |
Completed |
Study Name: Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors Condition: Kidney Cancer Date: 2012-02-29 Interventions:
|
Completed |
Study Name: Studying Gene Expression in Samples From Patients With Rhabdoid Tumors Condition:
Date: 2012-03-10 Interventions:
|
Withdrawn |
Study Name: Biomarker Study in Samples From Patients With Malignant Rhabdoid Tumor of the Kidney or Atypical Teratoid Rhabdoid Tumor Condition:
Date: 2011-10-01 Interventions:
|
Completed |
Study Name: Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Condition: Brain and Central Nervous System Tumors Date: 2002-10-03 Interventions: Drug: Oxaliplatin |
Completed |
Study Name: Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT Condition: Central Nervous System Tumor, Pediatric Date: 2004-06-10 Interventions:
|
Recruiting |
Study Name: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma Condition:
|